From: Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
Variable
Hazard ratio
95% CI
p
IPI score
2.792
1.407 - 5.544
0.003
STAT3 polymorphisms
2.787
1.346 - 5.773
0.006
B symptoms
0.420
0.210 - 0.839
0.014